FCG Advisors’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-76,865
Closed -$3.14M 114
2014
Q4
$3.14M Sell
76,865
-56,639
-42% -$1.69M 1.55% 13
2014
Q3
$4.12M Buy
133,504
+55,673
+72% +$1.6M 2.71% 8
2014
Q2
$2.17M Buy
77,831
+6,685
+9% +$193K 1.64% 14
2014
Q1
$2.13M Buy
71,146
+495
+0.7% +$17.1K 1.51% 17
2013
Q4
$2.15M Sell
70,651
-72,359
-51% -$1.99M 1.45% 16
2013
Q3
$4.5M Buy
143,010
+2,205
+2% +$50.6K 3.21% 7
2013
Q2
$2.13M Buy
+140,805
New +$1.95M 1.73% 14

Other funds holding NPSP

FCG Advisors's NPSP Position: Q1 2015 in Review

FCG Advisors sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 76,865 shares — an estimated $3.14M sold.

FCG Advisors first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $4.5M in Q3 2013. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • FCG Advisors reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • FCG Advisors sold 76,865 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $3.14M.
  • FCG Advisors first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • FCG Advisors's NPS PHARMACEUTICALS INC position peaked at $4.5M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on FCG Advisors's 13F filing for Q1 2015, filed 14 May 2015.